Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Miriplatin TACE study
jRCTs031180365Completed
- Start
- Jun 2017
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of miriplatin in hepatocellular carcinoma (HCC). Primary endpoint: Response rate. Started Jun 2017; status: completed.
02
Drugs
miriplatin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on jRCTs031180365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180365.